Sort   by:  
 Page size 
UnknownReal-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry.
Not available
S-EPMC8105236 | biostudies-literature
UnknownReal-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry.
Not available
S-EPMC7283204 | biostudies-literature
UnknownVorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.
Not available
S-EPMC8364866 | biostudies-literature
GenomicsTrachoma_GWAS_Unscarred_Controls
Gambian specimens with trachomatous scarring WHO grade C2/C3
EGAD00010000940 | EGA
GenomicsTrachoma_GWAS_Scarred_Cases
Gambian specimens without trachomatous scarring
EGAD00010000941 | EGA
GenomicsConjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study
This data comes from a genome-wide association study in 1090 cases of scarring trachoma and 1531 controls from a non-selected multi-ethnic sampling of The Gambia. The data constitutes hard base calls at 1457295 features from the HumanOmni2.5-8 (Omni2.5) BeadChip. Three genotype-calling algorithms we...
EGAS00001001516 | EGA
GenomicsWellcome Trust Sanger Institute Data Sharing Policy for Trachoma GWAS
Data Access Committee EGAC00001000489
EGAC00001000489 | EGA
UnknownAbiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Not available
S-EPMC9321995 | biostudies-literature
UnknownChronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.
Not available
S-EPMC4818564 | biostudies-literature
Sort   by:  
 Page size